GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (A7NB32)

Analyse AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A7NB32
Type
protein
Length
265 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xe33Eca57aeE4Ebe2c48b05dD1ffC9A854cfaCbe7
Molecule
3-methyl-2-oxobutanoate hydroxymethyltransferase
UniProt
A7NB32
Pockets
1 · best druggability 0.70

Structure

1 distinct chain · 44% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-methyl-2-oxobutanoate hydroxymethyltransferaseprotein26544% helix, 14% strandA7NB32

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11710.700.8835empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.